US5098692AExpiredUtilityPatentIndex 93
Calcium chelate and gadolinium pharmaceutical composition and methods of x-ray and nmr imaging
Est. expiryNov 28, 2006(expired)· nominal 20-yr term from priority
Y10T436/24A61K 49/0002Y10S424/90A61K 47/547A61K 47/6887A61P 43/00
93
PatentIndex Score
45
Cited by
23
References
25
Claims
Abstract
Improved metal complex-containing pharmaceutical agents are described which, as an additive, contain one or more complexing agents and/or one or more weak metal complex(es) or mixtures thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A pharmaceutical composition comprising a diagnostically effective amount of the gadolinium chelate complex of N 6 -carboxymethyl-N 3 ,N 9 -bis(methylcarbamoyl-methyl)-3,6,9-triazaundecanedioic acid, a pharmaceutically acceptable carrier and 2-10 mole % of a sodium salt of a calcium chelate complex, based on the amount of said gadolinium chelate complex, up to a maximum of 50 mmol/l of said composition, wherein said amount of calcium chelate complex is effective to enhance the safety in a human of said composition with respect to an identical composition except lacking said calcium chelate complex.
2. A composition of claim 1, wherein the amount of said sodium salt of a calcium chelate complex is 2-6 mole %.
3. A composition of claim 1 which is sterile.
4. A composition of claim 1, wherein said amount of sodium salt of a calcium chelate complex is up to a maxium of 30 mmol/l of said composition.
5. A composition of claim 1, wherein the amount of said gadolinium complex is between 1 micromole and 1 mole per liter.
6. A composition of claim 1, wherein the chelating agent of said sodium salt of a calcium chelate complex is the same as that of said gadolinium chelate complex.
7. A composition of claim 1, wherein the chelating agent of said sodium salt of a calcium chelate complex is different from that of said gadolinium chelate complex.
8. A method of obtaining an NMR image, comprising administering to a patient, of whom said image is to be obtained, a diagnostically effective amount of a pharmaceutical composition comprising a diagnostically effective amount of the gadolinium chelate complex of N 6 carboxymethyl-N 3 ,N 9 -bis(methylcarbamoylmethyl)3,6,9-troazaimdecamedopoc acid, a pharmaceutically acceptable carrier and 2-10 mole % of a sodium salt of a calcium chelate complex, based on the amount of said gadolinium chelate complex, up to a maximum of 50 mmol/l of said composition, wherein said amount of calcium chelate complex is effective to enhance the safety in a human of said composition with respect to an identical composition except lacking said calcium chelate complex, and taking said image.
9. A method of claim 8, wherein the amount of said sodium salt of a calcium chelate complex is 2-6 mole %.
10. A method of claim 8, wherein said composition is sterile.
11. A method of claim 8, wherein said amount of sodium salt of a calcium chelate complex is up to a maximum of 30 mmol/l of said composition.
12. A method of claim 8, wherein said amount of said gadolinium complex in said composition is between 1 micromole and 1 mole per liter.
13. A method of claim 8, wherein the chelating agent of said sodium salt of a calcium chelate complex is the same as that of said gadolinium chelate complex.
14. A method of claim 8, wherein the chelating agent of said sodium salt of a calcium chelate complex is different from that of said gadolinium chelate complex.
15. A method of claim 8, wherein the amount of the gadolinium chelate complex administered is between 0.001 and 5 mmol/kg.
16. A method of obtaining an X-ray image, comprising administering to a patient, of whom said image is to be obtained, a diagnostically effective amount of a pharmaceutical composition comprising a diagnostically effective amount of the gadolinium chelate complex of N 6 carboxymethyl-N 3 ,N 9 -bis(methylcarbamoylmethyl)-3,6,9-triazaundecanedioic acid, a pharmaceutically acceptable carrier and 2-10 mole % of a sodium salt of a calcium chelate complex, based on the amount of said gadolinium chelate complex, up to a maximum of 50 mmol/l of said composition, wherein said amount of calcium chelate complex is effective to enhance the safety in a human of said composition with respect to an identical composition except lacking said calcium chelate complex, and taking said image.
17. A method of claim 16, wherein the amount of said sodium salt of a calcium chelate complex is 2-6 mole %.
18. A method of claim 16, wherein said composition is sterile.
19. A method of claim 16, wherein said amount of sodium salt of a calcium chelate complex is up to a maximum of 30 mmol/l of said composition.
20. A method of claim 16, wherein the amount of said gadolinium complex in said composition is between 1 micromole and 1 mole per liter.
21. A composition of claim 16, wherein the chelating agent of said sodium salt of a calcium chelate complex is the same as that of said gadolinium chelate complex.
22. A method of claim 16, wherein the chelating agent of said sodium salt of a calcium chelate complex is different from that of said gadolinium chelate complex.
23. A method of claim 16, wherein the amount of the gadolinium chelate complex administered is between 0.001 and 5 mmol/kg.
24. A composition of claim 1, wherein said amount of sodium salt of a calcium chelate complex is 2-6 mole % based on the amount of said gadolinium chelate complex and is up to a maximum of 30 mmol/l of said composition, and wherein the chelating agent of said sodium salt of a calcium chelate complex is the same as that of said gadolinium chelate complex.
25. A method of claim 8, wherein said amount of sodium salt of a calcium chelate complex is 2-6 mole % based on the amount of said gadolinium chelate complex and is up to a maximum of 30 mmol/l of said composition, and wherein the chelating agent of said sodium salt of a calcium chelate complex is the same as that of said gadolinium chelate complex.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.